96 related articles for article (PubMed ID: 8106653)
1. Long-term treatment of major depressive disorder with paroxetine.
Duboff EA
J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):28S-33S. PubMed ID: 8106653
[TBL] [Abstract][Full Text] [Related]
2. Paroxetine versus placebo: a double-blind comparison in depressed patients.
Claghorn JL; Kiev A; Rickels K; Smith WT; Dunbar GC
J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of Paroxetine 20 mg daily in the treatment of depression and depression associated anxiety.
Chaudhry HR; Qureshi Z; Tareen IA; Yazdani I
J Pak Med Assoc; 2002 Nov; 52(11):518-25. PubMed ID: 12585372
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
5. Mirtazapine compared with paroxetine in major depression.
Benkert O; Szegedi A; Kohnen R
J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
[TBL] [Abstract][Full Text] [Related]
7. A double-blind comparison of paroxetine with imipramine in the long-term treatment of depression.
Claghorn JL; Feighner JP
J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):23S-27S. PubMed ID: 8106652
[TBL] [Abstract][Full Text] [Related]
8. Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice.
Ohrberg S; Christiansen PE; Severin B; Calberg H; Nilakantan B; Borup A; Søgaard J; Larsen SB; Loldrup D; Bahr B
Acta Psychiatr Scand; 1992 Dec; 86(6):437-44. PubMed ID: 1471536
[TBL] [Abstract][Full Text] [Related]
9. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients.
Kiev A; Feiger A
J Clin Psychiatry; 1997 Apr; 58(4):146-52. PubMed ID: 9164424
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine in the long-term treatment of major depressive disorder.
Raskin J; Goldstein DJ; Mallinckrodt CH; Ferguson MB
J Clin Psychiatry; 2003 Oct; 64(10):1237-44. PubMed ID: 14658974
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.
Ravindran AV; Judge R; Hunter BN; Bray J; Morton NH
J Clin Psychiatry; 1997 Mar; 58(3):112-8. PubMed ID: 9108813
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.
Anghelescu IG; Kohnen R; Szegedi A; Klement S; Kieser M
Pharmacopsychiatry; 2006 Nov; 39(6):213-9. PubMed ID: 17124643
[TBL] [Abstract][Full Text] [Related]
13. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
Schatzberg AF; Kremer C; Rodrigues HE; Murphy GM;
Am J Geriatr Psychiatry; 2002; 10(5):541-50. PubMed ID: 12213688
[TBL] [Abstract][Full Text] [Related]
15. Paroxetine and amitriptyline augmentation of lithium in the treatment of major depression: a double-blind study.
Bauer M; Zaninelli R; Müller-Oerlinghausen B; Meister W
J Clin Psychopharmacol; 1999 Apr; 19(2):164-71. PubMed ID: 10211918
[TBL] [Abstract][Full Text] [Related]
16. Lower side effects of milnacipran than paroxetine in the treatment of major depression disorder among Han Chinese in Taiwan.
Chang TT; Lêng CH; Wu JY; Lee SY; Wang YS; Chen YC; Lu RB
Chin J Physiol; 2008 Dec; 51(6):387-93. PubMed ID: 19280883
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, randomized, fluoxetine-controlled, multicenter study of paroxetine in the treatment of depression.
Tignol J
J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):18S-22S. PubMed ID: 8106650
[TBL] [Abstract][Full Text] [Related]
18. Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial.
Rapaport MH; Lydiard RB; Pitts CD; Schaefer D; Bartolic EI; Iyengar M; Carfagno M; Lipschitz A
J Clin Psychiatry; 2009 Jan; 70(1):46-57. PubMed ID: 19026248
[TBL] [Abstract][Full Text] [Related]
19. A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression.
Schöne W; Ludwig M
J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):34S-39S. PubMed ID: 8106654
[TBL] [Abstract][Full Text] [Related]
20. Paroxetine in the treatment of depressed patients with haematological malignancy: an open-label study.
Pae CU; Kim YJ; Won WY; Kim HJ; Lee S; Lee CU; Lee SJ; Kim DW; Lee C; Min WS; Kim CC; Paik IH; Serretti A
Hum Psychopharmacol; 2004 Jan; 19(1):25-9. PubMed ID: 14716708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
